Immune therapies have been explored as a way to treat cancer after it develops. But a new study suggests that genetic risk of prostate cancer can be reduced by rescuing critical immune system cells.
Immune therapies have been explored as a way to treat cancer after it develops. But a new study suggests that genetic risk of prostate cancer can be reduced by rescuing critical immune system cells.